Disease & disorder

vasculitis

MONDO:0018882

Vasculitis represents a clinically heterogenous group of diseases of multifactorial etiology characterized by inflammation of either large-sized vessels (large-vessel vasculitis, e.g. Giant-cell arteritis and Takayasu arteritis), medium-sized vessels (medium-vessel vasculitis e.g. polyarteritis nodosa and Kawasaki disease), or small-sized vessels (small-vessel vasculitis, e.g. granulomatosis with polyangiitis, microscopic polyangiitis, immunoglobulin A vasculitis, and cutaneous leukocytoclastic angiitis). Vasculitis occurs at any age, may be acute or chronic, and manifests with general symptoms such as fever, weight loss and fatigue, as well as more specific clinical signs depending on the type of vessels and organs affected. The degree of severity is variable, ranging from life or sight threatening disease (e.g. Behcet disease) to relatively minor skin disease.

Clinical trials19
Recruiting4
Drug concepts studied2
Synonyms1

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…

Clinical trials

19 shown
Generative AI Impact on Rheumatoid Arthritis Complications DiagnosisNCT07301892 · 2025-10-01
RECRUITING
Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic SettingNCT05012033 · 2023-04-12
RECRUITING
National Registry of Rare Kidney DiseasesNCT06065852 · 2009-11-06
RECRUITING
A Real-World Registry of Chronic Wounds and UlcersNCT02280733 · 2005-01-01
RECRUITING
Mass Spectrometry-based Immune Profiling in Autoimmune DiseasesNCT07188285 · 2025-05-25
ENROLLING_BY_INVITATION
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19NCT05115370 · 2021-11-01
COMPLETED
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26
UNKNOWN
Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology ClınıcNCT05292456 · 2021-02-01
UNKNOWN
Denosumab for Glucocorticoid-treated Children With Rheumatic DisordersNCT02418273 · 2019-08-01
WITHDRAWN
Smartphone Mindfulness Meditation for Patients With Rheumatic DiseasesNCT03937856 · 2019-05-07
TERMINATED
Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary SarcoidosisNCT03755245 · 2018-11-23
ENROLLING_BY_INVITATION
Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in RheumatologyNCT03459274 · 2018-03-16
UNKNOWN
Phenomics in Autoimmune and Inflammatory DiseasesNCT02466217 · 2015-07-29
COMPLETED
Pregnancy and Medically Assisted Conception in Rare DiseasesNCT02450396 · 2015-06-01
WITHDRAWN
Immunogenicity and Safety of Vaccinations in Immunocompromised PersonsNCT01947465 · 2013-10-01
COMPLETED
Improving the Quality of Patient Care by Using a Clinical Expert System.NCT00430755 · 2005-08-01
COMPLETED
Etanercept to Treat Wegener's GranulomatosisNCT00001901 · 1999-02-01
COMPLETED
Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityNCT03941184 · 1995-01-01
COMPLETED
Assessment of Patients With Multiple Sclerosis (MS)NCT00001156 · 1976-01-23
COMPLETED

Leading sponsors

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.